Skip to main content

Marta Rodríguez Barranco

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Marta Rodríguez Barranco

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Niveles en suero de neurofilamentos de cadena ligera como marcador pronóstico de evolución de la enfermedad y de respuesta al tratamiento en esclerosis múltiple

IP: Georgina Arrambide García
Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Cristina Auger Acosta, Marta Rodríguez Barranco, Joaquin Castillo Justribo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI19/01590
Duration: 01/01/2020 - 30/06/2024

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Gustavo Gimenez

Gustavo Gimenez

Predoctoral researcher
Infectious Diseases
Read more
Jorge Rodrigo Fernandez

Jorge Rodrigo Fernandez

Research technician
Cardiovascular Diseases
Read more
Silvia Alarcón Portabella

Silvia Alarcón Portabella

Research assistant
Read more
Susana González Suárez

Susana González Suárez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.